Damora Therapeutics (DMRA) Exchange Rate Effect (2019 - 2026)
Damora Therapeutics posted quarterly Exchange Rate Effect of -$48000.0 for Q1 2026, down 123.65% year-on-year from $203000.0 in Q1 2025, and down 166.67% on a QoQ basis from -$18000.0 in Q4 2025.
Damora Therapeutics (DMRA) has 8 years of Exchange Rate Effect data on file, last reported at -$48000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 123.65% year-over-year to -$48000.0; the trailing twelve-month figure through Mar 2026 stood at $454000.0 (up 1846.15% YoY), and the FY2025 full-year result was $705000.0, up 322.4% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$48000.0, down from -$18000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.5 million in Q4 2022 and bottomed at -$720000.0 in Q2 2022.
- The 5-year median for Exchange Rate Effect is -$18000.0 (2025), against an average of $58117.6.
- The widest annual swing landed in 2022, when Exchange Rate Effect jumped 949.15%; it then tumbled 563.16% in 2024.
- A 5-year view of Exchange Rate Effect shows it stood at $1.5 million in 2022, then tumbled by 81.3% to $281000.0 in 2023, then tumbled by 301.78% to -$567000.0 in 2024, then surged by 96.83% to -$18000.0 in 2025, then tumbled by 166.67% to -$48000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$48000.0 (Q1 2026), -$18000.0 (Q4 2025), and $11000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Damora Therapeutics | 853.36 Mn | 650.97 Mn | - | -48,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48,000.00 |
| Mar 31, 2026 | -48,000.00 |
| Dec 31, 2025 | -18,000.00 |
| Dec 31, 2025 | -18,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 509,000.00 |
| Jun 30, 2025 | 509,000.00 |
| Mar 31, 2025 | 203,000.00 |
| Mar 31, 2025 | 203,000.00 |
| Dec 31, 2024 | -567,000.00 |
| Dec 31, 2024 | -567,000.00 |
| Sep 30, 2024 | 467,000.00 |
| Sep 30, 2024 | 467,000.00 |
| Jun 30, 2024 | -129,000.00 |
| Jun 30, 2024 | -129,000.00 |
| Mar 31, 2024 | -88,000.00 |
| Mar 31, 2024 | -88,000.00 |
| Dec 31, 2023 | 281,000.00 |
| Dec 31, 2023 | 281,000.00 |
| Sep 30, 2023 | 120,000.00 |
| Sep 30, 2023 | 120,000.00 |
| Jun 30, 2023 | -36,000.00 |
| Jun 30, 2023 | -36,000.00 |
| Mar 31, 2023 | 19,000.00 |
| Mar 31, 2023 | 19,000.00 |
| Dec 31, 2022 | 1.50 Mn |
| Dec 31, 2022 | 1.50 Mn |
| Sep 30, 2022 | -348,000.00 |
| Sep 30, 2022 | -348,000.00 |
| Jun 30, 2022 | -720,000.00 |
| Jun 30, 2022 | -720,000.00 |
| Mar 31, 2022 | -171,000.00 |
| Mar 31, 2022 | -171,000.00 |
| Dec 31, 2021 | -177,000.00 |
| Dec 31, 2021 | -177,000.00 |
| Sep 30, 2021 | -369,000.00 |
| Sep 30, 2021 | -369,000.00 |
| Jun 30, 2021 | 233,000.00 |
| Jun 30, 2021 | 233,000.00 |
| Mar 31, 2021 | -604,000.00 |
| Mar 31, 2021 | -604,000.00 |
| Dec 31, 2020 | 989,000.00 |
| Dec 31, 2020 | 989,000.00 |
| Sep 30, 2020 | 2.15 Mn |
| Sep 30, 2020 | 2.15 Mn |
| Jun 30, 2020 | 199,000.00 |
| Jun 30, 2020 | 199,000.00 |
| Mar 31, 2020 | -210,000.00 |
| Mar 31, 2020 | -210,000.00 |
| Dec 31, 2019 | 2.19 Mn |
| Dec 31, 2019 | 2.19 Mn |